News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
535,470 Results
Type
Article (39097)
Company Profile (157)
Press Release (496197)
Multimedia
Podcasts (126)
Webinars (18)
Section
Business (151639)
Career Advice (1562)
Deals (29248)
Drug Delivery (137)
Drug Development (70783)
Employer Resources (129)
FDA (12276)
Job Trends (11484)
News (271131)
Policy (29820)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (2007)
Accelerated approval (45)
Adcomms (31)
Allergies (152)
Alliances (46837)
ALS (167)
Alzheimer's disease (1592)
Antibody-drug conjugate (ADC) (382)
Approvals (12508)
Artificial intelligence (520)
Autoimmune disease (208)
Automation (37)
Bankruptcy (279)
Best Places to Work (8891)
BIOSECURE Act (19)
Biosimilars (205)
Biotechnology (80)
Bladder cancer (141)
Brain cancer (74)
Breast cancer (566)
Cancer (4632)
Cardiovascular disease (381)
Career advice (1343)
Career pathing (32)
CAR-T (240)
CDC (69)
Cell therapy (672)
Cervical cancer (35)
Clinical research (61061)
Collaboration (1901)
Company closure (5)
Compensation (1236)
Complete response letters (90)
COVID-19 (2689)
CRISPR (93)
C-suite (843)
Cystic fibrosis (105)
Data (6146)
Decentralized trials (2)
Denatured (26)
Depression (145)
Dermatology (65)
Diabetes (483)
Diagnostics (4424)
Digital health (35)
Diversity (8)
Diversity, equity & inclusion (36)
Drug discovery (266)
Drug pricing (209)
Drug shortages (37)
Duchenne muscular dystrophy (254)
Earnings (59733)
Editorial (70)
Employer branding (17)
Employer resources (119)
Events (73685)
Executive appointments (806)
FDA (15226)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (15)
Frontotemporal dementia (27)
Funding (1270)
Gene editing (191)
Generative AI (50)
Gene therapy (637)
GLP-1 (1090)
Government (4680)
Grass and pollen (7)
Guidances (342)
Healthcare (12744)
HIV (70)
Huntington's disease (51)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (81)
Immunology and inflammation (233)
Immuno-oncology (81)
Indications (161)
Infectious disease (3023)
Inflammatory bowel disease (173)
Inflation Reduction Act (12)
Influenza (134)
Intellectual property (228)
Interviews (272)
IPO (12621)
IRA (52)
Job creations (2923)
Job search strategy (1134)
JPM (55)
Kidney cancer (13)
Labor market (73)
Layoffs (448)
Leadership (31)
Legal (7908)
Liver cancer (78)
Longevity (31)
Lung cancer (630)
Lymphoma (353)
Machine learning (44)
Management (41)
Manufacturing (893)
MASH (178)
Medical device (6793)
Medtech (6848)
Mergers & acquisitions (17705)
Metabolic disorders (1385)
mRNA (197)
Multiple sclerosis (163)
NASH (22)
Neurodegenerative disease (362)
Neuropsychiatric disorders (105)
Neuroscience (2914)
Neurotech (1)
NextGen: Class of 2026 (4320)
Non-profit (3031)
Now hiring (28)
Obesity (699)
Opinion (297)
Ovarian cancer (165)
Pain (203)
Pancreatic cancer (251)
Parkinson's disease (308)
Partnered (24)
Patents (471)
Patient recruitment (454)
Peanut (52)
People (43019)
Pharmaceutical (69)
Pharmacy benefit managers (26)
Phase 1 (18280)
Phase 2 (26673)
Phase 3 (21109)
Pipeline (7025)
Policy (333)
Postmarket research (2237)
Preclinical (7697)
Press Release (43)
Prostate cancer (228)
Psychedelics (58)
Radiopharmaceuticals (299)
Rare diseases (943)
Real estate (4176)
Recruiting (58)
Regulatory (22002)
Reports (29)
Research institute (1882)
Resumes & cover letters (229)
Rett syndrome (37)
RNA editing (16)
RSV (93)
Schizophrenia (174)
Series A (202)
Series B (139)
Service/supplier (5)
Sickle cell disease (88)
Special edition (20)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (2726)
State (2)
Stomach cancer (17)
Supply chain (114)
Tariffs (96)
The Weekly (98)
Vaccines (1152)
Venture capital (88)
Weight loss (482)
Women's health (80)
Worklife (14)
Date
Today (141)
Last 7 days (696)
Last 30 days (2626)
Last 365 days (23411)
2026 (9167)
2025 (23494)
2024 (26804)
2023 (30181)
2022 (39662)
2021 (42524)
2020 (40523)
2019 (33688)
2018 (25751)
2017 (25408)
2016 (24251)
2015 (28029)
2014 (22171)
2013 (18378)
2012 (19576)
2011 (20387)
2010 (18699)
Location
Africa (715)
Alabama (67)
Alaska (3)
Arizona (180)
Arkansas (9)
Asia (35632)
Australia (5719)
California (9346)
Canada (2952)
China (1156)
Colorado (406)
Connecticut (422)
Delaware (331)
Europe (79219)
Florida (1521)
Georgia (276)
Hawaii (4)
Idaho (36)
Illinois (791)
India (84)
Indiana (457)
Iowa (18)
Japan (474)
Kansas (101)
Kentucky (36)
Louisiana (26)
Maine (35)
Maryland (1279)
Massachusetts (6885)
Michigan (204)
Minnesota (386)
Mississippi (2)
Missouri (97)
Montana (25)
Nebraska (14)
Nevada (90)
New Hampshire (37)
New Jersey (2803)
New Mexico (20)
New York (2662)
North Carolina (1249)
North Dakota (7)
Northern California (4683)
Ohio (262)
Oklahoma (12)
Oregon (27)
Pennsylvania (1904)
Puerto Rico (23)
Rhode Island (30)
South America (1011)
South Carolina (44)
South Dakota (1)
Southern California (3721)
Tennessee (120)
Texas (1327)
United States (33673)
Utah (210)
Vermont (1)
Virginia (278)
Washington D.C. (60)
Washington State (732)
West Virginia (3)
Wisconsin (92)
Wyoming (2)
535,470 Results for "cns pharmaceuticals ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing
May 4, 2026
·
6 min read
Funding
Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases
George Church’s Rejuvenate Bio is turning to social networks to help fund its work on one-time gene therapies targeting chronic diseases and root causes of aging.
April 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents
February 9, 2026
·
7 min read
Press Releases
Neurogene Highlights Data at ASGCT Meeting Supporting Therapeutic Rationale for ICV Delivery Method in CNS-targeted Gene Therapy
May 12, 2026
·
8 min read
Press Releases
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
April 28, 2026
·
7 min read
Press Releases
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
April 28, 2026
·
5 min read
Press Releases
Acadia Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
March 13, 2026
·
1 min read
Press Releases
CNS Pharmaceuticals Announces CEO Transition
December 17, 2025
·
5 min read
Press Releases
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
March 11, 2026
·
1 min read
Press Releases
Oncotelic Therapeutics Announces Closing of a Strategic Monetization of Its CNS/Nasal Assets with Lunai Bioworks, Advancing Joint Development in Biodefense and Alzheimer’s Disease
May 6, 2026
·
6 min read
1 of 53,547
Next
